ResearchRaven Conferences Feed - Mood Disorders

Accelerating Translational Neurotechnology: Fourth Annual Aspen Brain Forum

ResearchRaven

Accelerating Translational Neurotechnology: Fourth Annual Aspen Brain Forum

September 18 - 20, 2013 Aspen Meadows Resort

Presented by The Aspen Brain Forum Foundation, Science Translational Medicine, and the New York Academy of Sciences

Neurotechnology encompasses electrical, chemical, and medical devices and products that can interact with or intervene in the activity of the central nervous system. These technologies include neuroprosthetics, neuroengineering, neuroimaging, optogenetics, neuromodulation, and neural stem cell therapies. Translating neurotechnologies from the laboratory into clinical and commercial products has been an arduous process. Yet many of these new tools show great potential to revolutionize the treatment of neurological diseases and disorders including depression, pain, headache, epilepsy, neuromuscular disease, Alzheimer's disease, Parkinson's disease, and traumatic brain injury.

Through a series of plenary sessions, panel discussions, and interactive breakout groups, this 2.5-day international conference shall explore innovative scientific, clinical, and organizational models for advancing the translation of neuroscience research into technology that can dramatically improve diagnosis and treatment of neurological and psychiatric disease. Participants will also examine the ethical and regulatory challenges in translating neuroscience research, and the potential economic impact of their clinical application.

This conference includes a breakout session. During registration, you will be asked to choose a work group based on your area/disease of interest. Please pick your first and second choices for this session. You may also write in an alternate topic. We will create additional groups if there is sufficient interest. Registrants will receive an email with work group details several weeks prior to the conference.

Choices include: Parkinson's Disease, Major Depression and other Mood Disorders, Chronic Pain, Alzheimer's Disease, or Traumatic Brain Injury.

7th Biennial Congress of the International Society of Affective Disorders

ResearchRaven

7th Biennial Congress of the International Society of Affective Disorders

28th – 30th April, 2014 Berlin, Germany

Affective disorders: integrated approaches for the 21st century

Join us at the Intercontinental in Berlin for the 7th Biennial Congress of The International Society of Affective Disorders, 28th – 30th April, 2014.

This major international conference aims to promote networking, exchange of ideas and experiences, and advance awareness of the consequence of mental health to global health and human development.

Although the affective disorders are not a clearly delineated group of illnesses they include unipolar and bipolar depression, generalised anxiety disorder, and more specific anxiety disorders such as agoraphobia, panic disorder and social phobia, obsessive-compulsive disorder and post-traumatic stress disorder (PTSD). There is a high level of similarity and co-morbidity among these illnesses and it is sensible to consider them as a single group.

Join us at ISAD 2014 if you are a clinical practitioner, clinical researcher, industry professional, nurse or other healthcare practitioners interested in affective disorders

25th Annual Psychiatric Pharmacotherapy Update

ResearchRaven

25th Annual Psychiatric Pharmacotherapy Update

October 24 & 25, 2013 Austin, Texas

The University of Texas at Austin College of Pharmacy is proud to be hosting the 25th Annual Psychiatric Pharmacotherapy Update, October 24 & 25, 2013 in Austin, Texas. This educational conference is presented by the College of Pharmacy's Continuing Pharmacy Education department and Psychiatric Pharmacy Program to meet the educational needs of practitioners who provide care to patients with mental health disorders.

Addressing Psychiatric Pharmacotherapy Topics Important for Today's Practice

This conference's goal is improve the quality of care delivered to people with mental health problems by providing timely and clinically useful information for the practicing clinician. Conference speakers focus on the practical application of neuroscience principles and evidence-based approaches to the treatment of serious and persistent major psychiatric and neurologic disorders, including depression, schizophrenia, bipolar, and dementias. Participants are provided with treatment advances in the psychiatric pharmacotherapy of children, traumatic brain injury, substance abuse, and an update on new psychotherapeutic uses of existing agents and new psychotropic agents that will impact your practice in the next year.

Inter-Professional

• Pharmacists

• Psychiatrists

• Physicians

• Nurses

• Psychologists

• Social Workers & Counselors

Who Should Attend

Pharmacists, psychiatrists, physicians, nurses, psychologists and social workers who specialize in or have an interest in neuropsychiatric disorders and wish to enhance their awareness and knowledge of the most recent advances impacting contemporary practice.

16th Annual Conference of the International Society of Bipolar Disorders

ResearchRaven

16th Annual Conference of the International Society of Bipolar Disorders

March 18-21, 2014 Seoul, South Korea

The 16th Annual Conference of the International Society of Bipolar Disorders will build on the world class reputation that this premier global bipolar disorder educational forum has established. Being held in the Asian metropolis of Seoul, South Korea, March 18-21, the Conference will bring together international scientists and clinicians to trade ideas, information and expertise.

Bipolar disorder is one of the most rapidly evolving areas of psychiatry. The Conference is a unique opportunity to share cutting edge findings and network with distinguished experts in the field.

For general inquiries regarding the Meeting, please contact:

Kenes International
1-3, Rue de Chantepoulet
P.O. Box 1726
CH-1211 Geneva 1
Switzerland
Tel: +41 22 908 0488
Fax: +41 22 906 9140

E-mail: isbd@kenes.com

10th International Conference on Bipolar Disorders

ResearchRaven

10th International Conference on Bipolar Disorders

June 13-16, 2013 Miami, Florida

For the first time in its history, the ICBD will be held in Miami Beach, Florida and not Pittsburgh on 13-16 June 2013. Clinicians, researchers, patients and consumers from around the world will again come togeth-er for this three-day conference to share their clinical expertise, research findings and personal experiences with the goal of improving the quality of life for those living with bipolar disorder.

Melancholy Minds and Painful Bodies: Genealogy, Geography, Pathogeny

ResearchRaven

Melancholy Minds and Painful Bodies: Genealogy, Geography, Pathogeny

University of Liverpool, United Kingdom 9-11 July 2013

One of the major developments in the study of melancholia over the last thirty years has been the rise to aesthetic and cultural prominence of varieties of negative emotions proposed and discussed as melancholy, including different conceptions, analyses, and portrayals from grief to insanity. Most recently, Lars von Trier’s film Melancholia(2011) happens to be the melodramatic adaptation of the concept fuelled by cinematic symbols. Correspondingly, often observed as ‘a central European discourse’, melancholia has resurfaced to embody complementary or paradoxical notions not merely in the literary analysis of texts and contexts, but it has also emerged to retrieve its historical categorization. The cultural and social history of emotions entwined with modern medical and psychiatric lexicalization has opened new pathways to provide relative definitions of melancholia. However, theories about the choice of analogies for melancholy, whether aesthetic, cinematic, religious, or medical, somehow fail to distinguish the connections between contrary factors involved in melancholia.

It is also noteworthy that theories of characterization, no matter of what kind, tend to reformulate and evaluate contrary factors for the sake of preserving ‘superiority’ according to prevalent taste at each moment in time. In Britain, for example, individual and collective melancholia has been appreciated as a sign of genius and national pride at one time and announced as a national malady at another. Analogous is the contemporary history of behavioural rather than cognitive attributes to grief, e.g. tearfulness. Pain, in comparison, is bodily and often mental distress which in the past was closely perceived in relation to melancholia, but today research on pain is divorced from depression let alone melancholy. Thus, we miss the ‘melancholy-pain bridge’ in contemporary scholarship of mental and physical suffering. On the other hand, while pain is seen through the lens of universality, with management models stretching from Chinese medicine to Latin America, melancholia has rarely been investigated beyond the Western borders with regard to its genealogy, pathology, pathogeny, and management. Whether this geographical focus is a matter of re-establishing pre-eminence or in want of psycholinguistic reference, thereby centred on a gap in universal scientific communication, it invites intriguing and challenging enquiries.

Possible topics

Diversity in the geography of melancholia and pain
The relationship between Western theories of emotions and Oriental conceptions
The European hypothesis of melancholia-pain in non-European cultures
Orientalism, grief, and abstinence
Emotionality as negativity
Gender attributes and tearfulness
Art history, muscle tension, and the painful posture
Interpretation, assumption, semantic relation
Fear, Pain, and melancholy dominance
Depression and pain
Paranoia, melancholia, and pain
Misconceptions; cyclothymia and bipolar disorder
Melancholy appropriation, ethnicity, multicultural perspectives
Cosmology and elegiac pain management
Cinematic symbols
Literary emotionality, fictive superiority
Embodied cognition
Anaesthetics, the relationship between medical management and other models
Lyric manifestation of melancholy and pain